The Therapeutic Potential of Cannabis and Cannabinoids

In Germany, a cannabis extract was approved in 2011 for the treatment of moderate to severe refractory spasticity in multiple sclerosis. It is commonly used off label for the treatment of anorexia, nausea, and neuropathic pain.

This information is for EDUCATIONAL PURPOSES only, not for diagnosing or treating any medical condition.